Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04832659 · ClinicalTrials.gov registry record · NA

Assessment of Biomarkers in Children to Help Parents Quit Tobacco

A NA study of Tobacco Dependence, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
865
Enrollment target
1
Study location

NCT04832659 is a NA study of Tobacco Dependence that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 865 participants, above the 448-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (93% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04832659, a NA study of Tobacco Dependence, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
865 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled trial will test whether adding biomarker measurement and informed outreach for tobacco smoke exposure as part of routine practice increases identification and improves treatment, effectiveness, and sustainability of a parental tobacco control intervention that will be integrated into pediatric practice.

Conditions Studied

Interventions

  • BEHAVIORAL CEASE
  • BEHAVIORAL CEASE + BIO

Study Locations (1)

Ohio

  • MetroHealth System - Cleveland

Trial Details

FieldValue
Enrollment Target 865 participants
Start Date 2023-01-20
Est. Completion 2026-02-28
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04832659

The ClinicalTrials.gov registry entry for NCT04832659 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 865 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 448-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (93% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 2 interventions - of which CEASE is the first listed.

NCT04832659 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04832659 about?

NCT04832659 is a clinical study titled "Assessment of Biomarkers in Children to Help Parents Quit Tobacco". This randomized controlled trial will test whether adding biomarker measurement and informed outreach for tobacco smoke exposure as part of routine practice increases identification and improves treatment, effectiveness, and sustainability of a parental tobacco control intervention that will be inte...

What is the current status of trial NCT04832659?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 865 participants. The study started on 2023-01-20. Estimated completion is 2026-02-28.

What conditions does trial NCT04832659 study?

This clinical trial studies the following conditions: Tobacco Dependence.

What interventions are being tested in trial NCT04832659?

The interventions under investigation include: CEASE (BEHAVIORAL), CEASE + BIO (BEHAVIORAL).

Who is sponsoring clinical trial NCT04832659?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04832659 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.